MELASMA: A HOSPITAL BASED RETROSPECTIVE STUDY ON CLINICOEPIDEMIOLOGICAL PROFILE
-
Published:2021-12-01
Issue:
Volume:
Page:23-25
-
ISSN:
-
Container-title:INDIAN JOURNAL OF APPLIED RESEARCH
-
language:en
-
Short-container-title:IJAR
Author:
Pandey Tanya1, Ahire Pranjal2, Someshwar Shylaja3
Affiliation:
1. Resident, Department of Dermatology, Venereology and Leprology, MGM Medical College and Hospital, Navi Mumbai. 2. Assistant Professor, Department of Dermatology, Venereology and Leprology, MGM Medical College and Hospital, Navi Mumbai. * 3. Professor and HOD, Department of Dermatology, Venereology and Leprology, MGM Medical College and Hospital, Navi Mumbai.
Abstract
Background: Melasma is a common, therapeutically challenging, psychological distressing, pigmentary disorder of sun
exposed skin.
Aim Of The Study: To study the clinical and epidemiological prole of melasma patients.
Materials And Methods: Tertiary care hospital retrospective study using data of melasma patients who attended the dermatology outpatient
clinic between February 2012 to May 2021. Study included 296 patients above 18 years. Demographic details were obtained from the pigment
clinic proforma.
Results: Mean age of 296 patients was 35.4 years, with female predominance (86.1%). Mean age at onset of melasma was 31.9 years.
Aggravation with sun exposure was noted in 64.2% cases. Family history was present in 15.2% cases while hypothyroidism in 3.4% cases. Malar
involvement was commonest (68.6%). Under Wood's lamp, epidermal type was commonest (57.4%). Cosmetic usage was present in 6.4% cases.
Pregnancy precipitation and pregnancy aggravation was noted in 16.5% and 9% females. 7.5% females reported OC pill usage.
Conclusion:This study showcases the multifaceted prole of patients aficted with melasma in a tertiary care hospital.
Publisher
World Wide Journals
Reference13 articles.
1. Grimes, P. E., Ijaz, S., Nashawati, R., & Kwak, D. (2019). New oral and topical approaches for the treatment of melasma. International Journal of Women’s Dermatology, 5(1), 30–36. 2. Pekmezci, E. (2019). A novel triple combination in treatment of melasma: Significant outcome with far less actives. Journal of Cosmetic Dermatology, 18(6), 1700–1704. 3. Ho, S. G. Y., Yeung, C. K., Chan, N. P. Y., Shek, S. Y., & Chan, H. H. L. (2013 August). A retrospective study of the management of Chinese melasma patients using a 1927-nm fractional thulium fiber laser. Journal of Cosmetic and Laser Therapy, 15(4), 200–206. 4. Sarma, N., Chakraborty, S., Poojary, S. A., Rathi, S., Kumaran, S., Nirmal, B., Felicita, J., Sarkar, R., Jaiswal, P., D’Souza, P., Donthula, N., Sethi, S., Ailawadi, P., & Joseph, B. (2017). Evidence-based review, grade of recommendation, and suggested treatment recommendations for melasma. Indian Dermatology Online Journal, 8(6), 406–442. 5. Lee, H. C., Thng, T. G. S., & Goh, C. Leok. (2016 August). Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. Journal of the American Academy of Dermatology, 75(2), 385–392.
|
|